Drug to Prevent Preterm Births to Be Pulled From Market

  • 📰 WSJ
  • ⏱ Reading Time:
  • 3 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

The maker of Makena said it will stop selling the drug to prevent preterm births after a study couldn’t confirm the medicine worked

Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works Makena was the only drug approved by the FDA to reduce the risk of preterm birth in women with a history of early deliveries.

Covis Pharma Group said it will stop selling its
Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 98. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

just call it a supplement and nobody says diddly

How did it get approved in the first place?

Good, do aducanumab next.

Wtf are these things let out before we know this. Jesus f----- Christ

Nederland Laatste Nieuws, Nederland Headlines